
Raymond K. Covington
Examiner (ID: 10694)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1622, 1209, 1107, 1612, 1625, 1203, 1206 |
| Total Applications | 2419 |
| Issued Applications | 1879 |
| Pending Applications | 78 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9672018
[patent_doc_number] => 20140235881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-21
[patent_title] => 'METHOD FOR PRODUCING 5-HYDROXYMETHYL-2-FURFURAL OR ALKYL ETHER DERIVATIVES THEREOF USING AN ION EXCHANGE RESIN IN THE PRESENCE OF AN ORGANIC SOLVENT'
[patent_app_type] => utility
[patent_app_number] => 14/348566
[patent_app_country] => US
[patent_app_date] => 2012-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6523
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14348566
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/348566 | Method for producing 5-hydroxymethyl-2-furfural or alkyl ether derivatives thereof using an ion exchange resin in the presence of an organic solvent | Jul 8, 2012 | Issued |
Array
(
[id] => 9977733
[patent_doc_number] => 09024044
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Heteroarylcarboxylic acid ester derivative'
[patent_app_type] => utility
[patent_app_number] => 13/517805
[patent_app_country] => US
[patent_app_date] => 2012-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20906
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13517805
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/517805 | Heteroarylcarboxylic acid ester derivative | Jun 13, 2012 | Issued |
Array
(
[id] => 9060009
[patent_doc_number] => 08546444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-01
[patent_title] => 'Synthetic lactone formulations and method of use'
[patent_app_type] => utility
[patent_app_number] => 13/481935
[patent_app_country] => US
[patent_app_date] => 2012-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4820
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13481935
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/481935 | Synthetic lactone formulations and method of use | May 27, 2012 | Issued |
Array
(
[id] => 10870378
[patent_doc_number] => 08895576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-25
[patent_title] => 'Methods of use of cyclopamine analogs'
[patent_app_type] => utility
[patent_app_number] => 13/475352
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20717
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475352
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475352 | Methods of use of cyclopamine analogs | May 17, 2012 | Issued |
Array
(
[id] => 8791614
[patent_doc_number] => 20130108583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-02
[patent_title] => 'METHODS OF USE FOR CYCLOPAMINE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 13/475510
[patent_app_country] => US
[patent_app_date] => 2012-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20663
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13475510
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/475510 | METHODS OF USE FOR CYCLOPAMINE ANALOGS | May 17, 2012 | Abandoned |
Array
(
[id] => 8371246
[patent_doc_number] => 20120220634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'Taxane Compounds, Compositions And Methods'
[patent_app_type] => utility
[patent_app_number] => 13/455455
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13864
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13455455
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/455455 | Taxane compounds, compositions and methods | Apr 24, 2012 | Issued |
Array
(
[id] => 9977734
[patent_doc_number] => 09024046
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Reductive amination process for preparation of dronedarone using amine intermediary compound'
[patent_app_type] => utility
[patent_app_number] => 14/007170
[patent_app_country] => US
[patent_app_date] => 2012-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5942
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007170
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/007170 | Reductive amination process for preparation of dronedarone using amine intermediary compound | Mar 26, 2012 | Issued |
Array
(
[id] => 9875600
[patent_doc_number] => 08962869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-02-24
[patent_title] => 'Process for synthesizing keto benzofuran derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/006027
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10897
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006027
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/006027 | Process for synthesizing keto benzofuran derivatives | Mar 22, 2012 | Issued |
Array
(
[id] => 9223778
[patent_doc_number] => 20140018553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'PROCESS FOR SYNTHESIZING KETO-BENZOFURAN DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/006787
[patent_app_country] => US
[patent_app_date] => 2012-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12311
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14006787
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/006787 | PROCESS FOR SYNTHESIZING KETO-BENZOFURAN DERIVATIVES | Mar 22, 2012 | Abandoned |
Array
(
[id] => 8278552
[patent_doc_number] => 20120172424
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-05
[patent_title] => 'CHROMAN DERIVATIVES, MEDICAMENTS AND USE IN THERAPY'
[patent_app_type] => utility
[patent_app_number] => 13/415697
[patent_app_country] => US
[patent_app_date] => 2012-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15846
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415697
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/415697 | Chroman derivatives, medicaments and use in therapy | Mar 7, 2012 | Issued |
Array
(
[id] => 8834750
[patent_doc_number] => 08450506
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-05-28
[patent_title] => 'Compounds and their salts specific to the PPAR receptors and the EGF Receptors and their use in the medical field'
[patent_app_type] => utility
[patent_app_number] => 13/397245
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10529
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13397245
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/397245 | Compounds and their salts specific to the PPAR receptors and the EGF Receptors and their use in the medical field | Feb 14, 2012 | Issued |
Array
(
[id] => 9983859
[patent_doc_number] => 09029574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-12
[patent_title] => 'Bicyclic compound and use thereof for medical purposes'
[patent_app_type] => utility
[patent_app_number] => 13/982001
[patent_app_country] => US
[patent_app_date] => 2012-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 62553
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13982001
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/982001 | Bicyclic compound and use thereof for medical purposes | Jan 25, 2012 | Issued |
Array
(
[id] => 8780821
[patent_doc_number] => 20130102797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-25
[patent_title] => 'Co-Crystal Compound, Method for Preparing the Same and Oxidant of Gas Generator Propellant'
[patent_app_type] => utility
[patent_app_number] => 13/354993
[patent_app_country] => US
[patent_app_date] => 2012-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 2619
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354993
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/354993 | Co-crystal compound, method for preparing the same and oxidant of gas generator propellant | Jan 19, 2012 | Issued |
Array
(
[id] => 10882731
[patent_doc_number] => 08907111
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-09
[patent_title] => 'Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments'
[patent_app_type] => utility
[patent_app_number] => 13/354254
[patent_app_country] => US
[patent_app_date] => 2012-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 22385
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13354254
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/354254 | Neuraminidase inhibitor compounds, compositions and methods for the use thereof in anti-viral treatments | Jan 18, 2012 | Issued |
Array
(
[id] => 8363746
[patent_doc_number] => 08252811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/338835
[patent_app_country] => US
[patent_app_date] => 2011-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28478
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13338835
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/338835 | Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof | Dec 27, 2011 | Issued |
Array
(
[id] => 9198901
[patent_doc_number] => 20130338216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'DEUTERATED AND/OR FLUORINATED TAXANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/995058
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10639
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995058
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/995058 | DEUTERATED AND/OR FLUORINATED TAXANE DERIVATIVES | Dec 21, 2011 | Abandoned |
Array
(
[id] => 10169253
[patent_doc_number] => 09199954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-01
[patent_title] => 'Non-ring hydroxy substituted taxanes and methods for synthesizing the same'
[patent_app_type] => utility
[patent_app_number] => 13/995445
[patent_app_country] => US
[patent_app_date] => 2011-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6702
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13995445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/995445 | Non-ring hydroxy substituted taxanes and methods for synthesizing the same | Dec 21, 2011 | Issued |
Array
(
[id] => 8503358
[patent_doc_number] => 20120302766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'SOLUTE-ENHANCED PRODUCTION OF GAMMA-VALEROLACTONE (GVL) FROM AQUEOUS SOLUTIONS OF LEVULINIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/327468
[patent_app_country] => US
[patent_app_date] => 2011-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16401
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13327468
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/327468 | Solute-enhanced production of gamma-valerolactone (GVL) from aqueous solutions of levulinic acid | Dec 14, 2011 | Issued |
Array
(
[id] => 9042651
[patent_doc_number] => 20130245289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'Process for producing perfluorinated organic compounds'
[patent_app_type] => utility
[patent_app_number] => 13/885867
[patent_app_country] => US
[patent_app_date] => 2011-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4634
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885867
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/885867 | Process for producing perfluorinated organic compounds | Nov 16, 2011 | Issued |
Array
(
[id] => 9162303
[patent_doc_number] => 20130310580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-21
[patent_title] => 'Method For Producing Optically Active Fluorine-Containing Oxeten'
[patent_app_type] => utility
[patent_app_number] => 13/989662
[patent_app_country] => US
[patent_app_date] => 2011-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4543
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13989662
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/989662 | Method for producing optically active fluorine-containing oxeten | Nov 15, 2011 | Issued |